Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine.
Saved in:
| Title: | Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine. |
|---|---|
| Authors: | Lassaunière R; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Polacek C; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Frische A; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Boding L; Danish National Biobank, Statens Serum Institut, Copenhagen, Denmark., Sækmose SG; Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark., Rasmussen M; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Fomsgaard A; Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark. |
| Source: | JAMA network open [JAMA Netw Open] 2022 May 02; Vol. 5 (5), pp. e2212073. Date of Electronic Publication: 2022 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2022.12073 |
